Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211783 · ClinicalTrials.gov registry record
Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in Autism
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 71
- Enrollment target
NCT00211783: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT00211783 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00211783 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 71 participants
- Enrollment target
Study Summary
This study investigates face processing, response inhibition and phoneme processing in autistic adults by fMRI.
Primary Outcome
Differences in BOLD betweens controls and ASD group BOLD - blood-oxygen-level-dependent contrast
Interventions
- PROCEDURE fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2004-11 |
| Est. Completion | 2012-06 |
What the finished NCT00211783 record still lists
NCT00211783 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 71 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which fMRI is the first listed.
NCT00211783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00211783 about?
NCT00211783 is a clinical study titled "Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in Autism". This study investigates face processing, response inhibition and phoneme processing in autistic adults by fMRI.
What is the current status of trial NCT00211783?
This trial is currently completed. The enrollment target is 71 participants. The study started on 2004-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00211783?
The interventions under investigation include: fMRI (PROCEDURE).
Who is sponsoring clinical trial NCT00211783?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia